The elucidation of the roles of TUG1 and HuR in apoptosis not only enhances our understanding of the molecular underpinnings of ischemic stroke but also lays the groundwork for developing therapeutic strategies targeting HuR, potentially improving outcomes and quality of life for stroke patients. This evidence concerns the gene ELAVL1 and ischemic stroke.